Condition
Recurrent Medulloblastoma clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Recurrent Medulloblastoma clinical trials that are recruiting, in United States. By phase: Phase 1 (2), Phase 2 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1Country
Newest Recurrent Medulloblastoma clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| 177Lu-DTPA-omburtamab for kids with recurring medulloblastoma or brain/CNS metastases | Phase 1 | Basking Ridge, New Jersey and 6 other locations | Recruiting | Jul 13, 2026 |
| GPC2-targeted CAR T cell therapy for relapsed or refractory medulloblastoma in children and young adults | Phase 1 | Palo Alto, California | Recruiting | Jul 25, 2025 |
| Lutathera treatment for recurrent high-grade brain tumors | Phase 1/2 | Aurora, Colorado and 3 other locations | Recruiting | Mar 14, 2022 |
| PEP-CMV vaccine for treating pediatric brain tumors | Phase 2 | Aurora, Colorado and 12 other locations | Recruiting | Oct 27, 2021 |
All recruiting trials (4)
-
177Lu-DTPA-omburtamab for kids with recurring medulloblastoma or brain/CNS metastases
This study tests whether 177Lu-DTPA-omburtamab can be safely given to children and adolescents with recurrent or refractory medulloblastoma or cancer that has spread to the CNS.
-
GPC2-targeted CAR T cell therapy for relapsed or refractory medulloblastoma in children and young adults
This trial will test whether autologous GPC2-targeted CAR T cells delivered into the brain ventricle are safe and active for children and young adults with relapsed or refractory medulloblastoma or similar CNS embryonal tumors.
-
Lutathera treatment for recurrent high-grade brain tumors
This study is testing if Lutathera can safely help children and young adults with recurring high-grade brain tumors that show certain markers on scans.
-
PEP-CMV vaccine for treating pediatric brain tumors
This study is testing a new vaccine for kids with certain types of brain tumors to see if it can help them feel better when used with a common chemotherapy drug.
Related topics
Quick answers
How many Recurrent Medulloblastoma clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2, Phase 2: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.